Medsinglong completes Series B funding to accelerate global warehouse network expansion

Guangzhou Medsinglong Medical Equipment Co., Ltd. ("Medsinglong"), a company focused on the medical device overseas expansion sector, recently announced the completion of a Series B funding round raising tens of millions of RMB. This round was jointly invested by the Yongfeng County Mother Fund managed by Jiangxi Gantou Investment and Plum Ventures.

Previously, Medsinglong has completed three prior funding rounds: it secured millions of RMB in Angel funding in 2017, raised tens of millions of RMB in a Pre-A round in 2019, and obtained another tens of millions of RMB in a Series A round in October 2024.

Medsinglong, founded in 2013, is a company specializing in cross-border medical device expansion, with its business now covering over 200 countries and regions worldwide. The company has successfully validated a "online customer acquisition + offline local presence" model in Mexico, achieving deep customer engagement and efficient expansion of local distribution networks. This model has since been replicated in more than ten countries.

The company is committed to building a digitalized medical device export platform driven by both technology and service. By integrating products, supply chain, and client-side operations through its self-developed IT system, and enhancing inventory management and logistics capabilities via overseas warehouses, Medsinglong aims to establish 200 overseas warehouses across 100 countries within the next decade. This network will enable 24-hour delivery and after-sales support, supported by the deployment of over 5,000 overseas-based staff to further deepen its global presence.